Danaher Co. (NYSE:DHR) Shares Sold by WealthPlan Investment Management LLC

WealthPlan Investment Management LLC decreased its holdings in shares of Danaher Co. (NYSE:DHR) by 2.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 25,688 shares of the conglomerate’s stock after selling 748 shares during the quarter. WealthPlan Investment Management LLC’s holdings in Danaher were worth $5,897,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently bought and sold shares of the company. Heck Capital Advisors LLC bought a new position in Danaher during the fourth quarter valued at about $27,000. Decker Retirement Planning Inc. acquired a new position in Danaher in the 4th quarter valued at approximately $31,000. Golden State Wealth Management LLC acquired a new stake in Danaher during the fourth quarter worth $31,000. Strategic Financial Concepts LLC acquired a new position in Danaher in the fourth quarter worth about $31,000. Finally, Pineridge Advisors LLC lifted its position in shares of Danaher by 63.3% during the 4th quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock worth $34,000 after buying an additional 57 shares during the period. Institutional investors and hedge funds own 79.05% of the company’s stock.

Insiders Place Their Bets

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the firm’s stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the sale, the senior vice president now directly owns 20,230 shares in the company, valued at $4,534,149.90. This trade represents a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Insiders own 11.10% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have commented on the stock. Royal Bank of Canada reissued an “outperform” rating and set a $277.00 price objective (down previously from $299.00) on shares of Danaher in a report on Thursday, January 30th. Guggenheim initiated coverage on shares of Danaher in a research note on Thursday, December 19th. They issued a “buy” rating and a $275.00 target price on the stock. JPMorgan Chase & Co. cut their price target on shares of Danaher from $310.00 to $300.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 28th. KeyCorp raised their target price on shares of Danaher from $290.00 to $310.00 and gave the stock an “overweight” rating in a report on Wednesday, October 23rd. Finally, Citigroup dropped their target price on shares of Danaher from $285.00 to $265.00 and set a “buy” rating on the stock in a report on Thursday, January 30th. Seven investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat, Danaher has an average rating of “Moderate Buy” and an average target price of $278.00.

Danaher Trading Up 1.5 %

DHR opened at $206.66 on Friday. The stock has a market cap of $149.26 billion, a PE ratio of 39.14, a price-to-earnings-growth ratio of 2.68 and a beta of 0.83. Danaher Co. has a twelve month low of $196.80 and a twelve month high of $281.70. The company has a fifty day moving average of $230.00 and a 200-day moving average of $249.96. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31.

Danaher (NYSE:DHR) last released its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter last year, the company earned $2.09 EPS. On average, sell-side analysts predict that Danaher Co. will post 7.67 EPS for the current year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, January 31st. Stockholders of record on Friday, December 27th were issued a $0.27 dividend. The ex-dividend date was Friday, December 27th. This represents a $1.08 annualized dividend and a dividend yield of 0.52%. Danaher’s dividend payout ratio is currently 20.45%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.